Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

But that's not so. Indirect costs include lab space, data storage, regulatory compliance and administrative support. The ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025 ... So far, there are no approved treatments for the ultra-rare disease, which causes about 50% of patients to progress ...

Advice is also provided on treatment strategies ... cardiovascular disease. Conclusion The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

Investors were feeling zen on Wednesday, with no major news about Donald Trump's tariffs to worry about ahead of the monthly ...

The productivity gap in research widens as male researchers utilize AI more effectively. Targeted interventions are needed to ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...